A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain

Study Identifier
M11-891
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Pain
  • Study Drug
  • ABT-639
  • pregabalin
  • Placebo
  • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18 - 75 Years

    Protocol Summary

    People with diabetes can, over time develop nerve damage throughout the body with symptoms such as pain, tingling, or numbness (loss of feeling) in the hands, arms, feet and legs.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 51807
    Little Rock, Arkansas, United States, 72204
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 51946
    Anaheim, California, United States, 92801
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 51468
    Long Beach, California, United States, 90806
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 52744
    Walnut Creek, California, United States, 94598
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 51079
    Clearwater, Florida, United States, 33765
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 51076
    Hialeah, Florida, United States, 33012
    Status
    Not applicable
    Showing {first} - {last} of {total} Results